Public Profile

Intas

Intas Pharmaceuticals Ltd, commonly referred to as Intas, is a prominent player in the global pharmaceutical industry, headquartered in India. Established in 1977, the company has significantly expanded its operations across various regions, including Europe, the United States, and Asia. Intas focuses on the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including generic and specialty medicines, biosimilars, and over-the-counter (OTC) drugs. With a commitment to quality and innovation, Intas has achieved notable milestones, such as receiving multiple approvals from regulatory authorities worldwide. The company’s core offerings are distinguished by their affordability and accessibility, making essential healthcare solutions available to a broader audience. Intas has solidified its market position through strategic partnerships and a robust pipeline, earning recognition for its contributions to the healthcare sector.

DitchCarbon Score

How does Intas's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

14

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

Industry Benchmark

Intas's score of 14 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Intas's reported carbon emissions

Intas, headquartered in India, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Intas may be engaging in efforts aligned with industry standards, but specific details on their climate commitments or emissions reductions are not provided.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Intas's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Intas is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Intas is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Eli Lilly and Company

GB
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Akums Drugs and Pharmaceuticals Limited

IN
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Glenmark Pharmaceuticals

IN
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Ipca Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Emcure

IN
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Aspen Pharmacare

ZA
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers